MONTAGNANI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 20.078
NA - Nord America 16.597
AS - Asia 9.062
SA - Sud America 1.641
AF - Africa 591
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 19
Totale 48.035
Nazione #
US - Stati Uniti d'America 16.191
IT - Italia 5.181
RU - Federazione Russa 4.188
GB - Regno Unito 2.974
SG - Singapore 2.642
CN - Cina 2.604
IE - Irlanda 2.076
BR - Brasile 1.349
DE - Germania 1.336
VN - Vietnam 1.229
SE - Svezia 917
FR - Francia 896
HK - Hong Kong 815
FI - Finlandia 736
UA - Ucraina 655
KR - Corea 379
IN - India 369
NL - Olanda 331
ZA - Sudafrica 323
CA - Canada 235
ES - Italia 180
BD - Bangladesh 143
PL - Polonia 117
IQ - Iraq 110
TR - Turchia 101
AR - Argentina 94
AT - Austria 93
MX - Messico 93
JP - Giappone 77
BE - Belgio 70
IR - Iran 70
PK - Pakistan 64
ID - Indonesia 60
CZ - Repubblica Ceca 57
CI - Costa d'Avorio 48
NG - Nigeria 48
UZ - Uzbekistan 47
CH - Svizzera 45
PH - Filippine 45
CO - Colombia 40
EC - Ecuador 40
SA - Arabia Saudita 38
AU - Australia 36
AE - Emirati Arabi Uniti 34
MY - Malesia 34
KE - Kenya 32
VE - Venezuela 32
EG - Egitto 31
LT - Lituania 27
JO - Giordania 25
CL - Cile 24
MA - Marocco 23
PE - Perù 22
AZ - Azerbaigian 21
PT - Portogallo 21
IL - Israele 19
RO - Romania 19
JM - Giamaica 18
PY - Paraguay 18
AL - Albania 17
DZ - Algeria 17
NP - Nepal 17
TN - Tunisia 17
BG - Bulgaria 16
EU - Europa 16
ET - Etiopia 14
LV - Lettonia 14
DK - Danimarca 13
UG - Uganda 13
CR - Costa Rica 12
EE - Estonia 11
HU - Ungheria 11
KZ - Kazakistan 11
OM - Oman 11
SK - Slovacchia (Repubblica Slovacca) 11
BO - Bolivia 10
GR - Grecia 10
PA - Panama 10
PS - Palestinian Territory 10
TT - Trinidad e Tobago 10
UY - Uruguay 10
HR - Croazia 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
TW - Taiwan 8
AM - Armenia 7
BY - Bielorussia 7
GE - Georgia 7
LB - Libano 7
RS - Serbia 7
BH - Bahrain 6
CY - Cipro 6
LK - Sri Lanka 6
LU - Lussemburgo 6
MD - Moldavia 6
SN - Senegal 6
AO - Angola 5
DO - Repubblica Dominicana 5
SI - Slovenia 5
SV - El Salvador 5
Totale 47.946
Città #
Dallas 4.117
Southend 2.391
Dublin 2.028
Singapore 1.566
Moscow 1.202
Chandler 1.114
Ashburn 1.098
Santa Clara 843
San Jose 783
Hong Kong 755
Beijing 685
Munich 666
Milan 599
Fairfield 557
Hefei 517
Siena 514
Jacksonville 508
Helsinki 500
Los Angeles 418
New York 368
Seoul 368
Ann Arbor 365
Ho Chi Minh City 342
Rome 328
Princeton 303
Woodbridge 282
Johannesburg 272
Florence 265
Hanoi 262
Council Bluffs 252
Wilmington 242
Lauterbourg 238
Seattle 233
Cambridge 192
The Dalles 188
Houston 186
Nanjing 185
Dong Ket 182
São Paulo 137
Menlo Park 136
Boardman 126
Buffalo 118
Shanghai 108
Frankfurt am Main 107
Orem 105
Málaga 93
Turku 88
Toronto 87
Turin 85
Nuremberg 84
Chennai 83
Chicago 82
San Mateo 82
London 81
Düsseldorf 79
Naples 75
Warsaw 74
Bologna 72
Montreal 68
Tokyo 67
Bengaluru 63
Nanchang 63
Brussels 62
Dearborn 60
Denver 54
Redondo Beach 54
Brescia 53
Lancaster 53
Stockholm 52
Vienna 52
Brooklyn 50
Da Nang 50
Portsmouth 50
Atlanta 49
Abidjan 48
Fremont 48
Genoa 48
San Diego 46
Baghdad 44
Amsterdam 43
Guangzhou 43
Shenyang 43
Haiphong 42
Lappeenranta 42
Rio de Janeiro 42
Tashkent 42
Phoenix 41
Washington 41
Catania 38
Poplar 38
San Francisco 38
Changsha 36
Paris 35
Abuja 34
Palermo 34
Redwood City 34
Mexico City 32
Bari 31
Boston 30
Tianjin 30
Totale 29.739
Nome #
Utilizzo di dalbavancina nella terapia delle infezioni osteoarticolari 1.348
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 629
A first update on mapping the human genetic architecture of COVID-19 576
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 575
Staphylococcus aureus vaccine preclinical and clinical development: current state of the art 567
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 561
MENINGITE VIRALE DA HHV7. DESCRIZIONE DI UN CASO IN ADULTO IMMUNOCOMPETENTE 546
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 539
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 508
Crisi comiziale generalizzata in giovane paziente proveniente dal Togo 443
Genetic mechanisms of critical illness in COVID-19 412
Analisi di clonalità di isolati di Streptococcus pyogenes resistenti ai macrolidi: fluttuazioni della dinamica di popolazione negli ultimi 8 anni 399
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 388
An explainable model of host genetic interactions linked to COVID-19 severity 366
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 365
Analisi della sensibilità a penicillina in isolati comunitari di Streptococcus pneumoniae: implicazioni cliniche in relazione alle concentrazioni minime inibenti 360
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 344
Pathogen-sugar interactions revealed by universal saturation transfer analysis 323
null 320
Peripheral biomarkers' panel for severe COVID-19 patients 317
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 315
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 314
Analisi preliminare sull’impatto clinico-organizzativo della gestione delle ABSSSI: focus sui criteri di dimissione precoce 309
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 308
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 304
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 300
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 299
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 294
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 293
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 290
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 289
Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes 287
Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin 286
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 286
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 283
Case Report: Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy 281
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 277
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 275
Strategie di vaccinazione anti-pneumococcica nel paziente adulto HIV-positivo: confronto fra vaccino coniugato 13-valente e vaccino polisaccaridico 23-valente 275
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 274
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 270
Evolution of macrolide resistance in streptococcus pyogenes over 14 years in an area of central Italy 270
Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate Vaccine 268
First report of spondylodiscitis due to vancomycin heteroresistant Staphylococcus capitis in immunocompetent host 266
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region 264
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 259
Prognostic bioindicators in severe COVID-19 patients 254
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 254
Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study 253
Valutazione microbiologica del rischio infettivo nella chirurgia della cataratta 253
Pediatric spinal epidural abscess in an immunocompetent host without risk factors: Case report and review of the literature 253
Serial KL-6 measurements in COVID-19 patients 246
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 245
Clinical and microbiological features of acute bacterialconjunctivitis at the primary eye care unit in a hospital of centralItaly 244
ERADICAZIONE DI INFEZIONE DA HCV DOPO TRATTAMENTO DI 8 SETTIMANE CON GRAZOPREVIR/ELBASVIR: CASE REPORT 243
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 242
Antimicrobial Susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: Surveillance from 1993 to 2004 in Central Italy 239
Approccio perinatale al neonato che ha presentato malessere fetale 238
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. 237
Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients 235
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 235
Clindamycin-resistant Streptococcus pneumoniae 233
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 233
Un caso di “insolita” spondilodiscite da Staphylococcus capitis 232
Serotype distribution, clonality and antimicrobial resistance of invasive pneumococcal isolates in a central Italian region: implications for vaccine strategies 230
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 230
Resistenza ai beta-lattamici in Streptococcus pneumoniae: 10 anni di sorveglianza nell’area senese 229
Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 229
Clinical and microbiological features of acute bacterial conjunctivitis at the primary eye care unit in a hospital of central Italy 229
Descrizione di un'epidemia da Enterobacteriaceae multiresistenti in un'unità di terapia intensiva neonatale 226
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 224
Risposta immunitaria a lungo termine dopo vaccinazione antipneumococcica con vaccino coniugato 13-valente o vaccino polisaccaridico 23-valente in adulti HIV positivi 223
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 223
Meningite postchirurgica e infezione di cute e tessuti molli da Acinetobacter baumannii extensively drug resistant (XDR) 221
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 221
Discovery of new Mycoplasma pneumoniae antigens by use of a whole genome lambda display library 220
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review 218
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 216
Diagnosi di sarcoidosi in nuova diagnosi di HIV 216
Sierotipizzazione di isolati invasivi di Streptococcus pneumoniae: utilità della PCR multiplex nella sorveglianza epidemiologica 214
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 213
Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006 212
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 211
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 210
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 210
Ridotta sensibilità a penicillina in Streptococcus pneumoniae: analisi microbiologica di ceppi di recente isolamento 208
Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia 208
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 207
MIASI CAVITARIA A LOCALIZZAZIONE NASALE DA OESTRUS OVIS: UN CASO CLINICO 207
Prevalence of M75 Streptococcus Pyogenes strains harboring slaa gene in patients affected by pediatric obstructive sleep apnea syndrome in Central Italy 207
Casistica di malattia reumatica e glomerulonefrite poststreptococcica: patologie passate o riemergenti? 206
A complex outbreak of multiresistant Enterobacteriaceae producing the acquired AmpC-type beta-lactamase FOX-7 in a neonatal intensive care unit setting 206
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 206
PATOGENI COLONIZZANTI IL NASOFARINGE DI SOGGETTI HIV POSITIVI E HIV NEGATIVI 205
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 205
Evoluzione ed efficace controllo di un vasto focolaio epidemico nosocomiale da Klebsiella pneumoniae produttrice di carbapenemasi in un’area Neurochirurgica: lezioni apprese. 204
WES profiling of COVID-19 204
Un raro caso di osteomielite da Moraxella osloensis e Staphylococcus capitis in giovane paziente immunocompetente 203
Whole-genome sequencing reveals host factors underlying critical COVID-19 200
Sierotipizzazione, clonalità e chemiosensibilità di isolati invasivi di Streptococcus pneumoniae nell'area senese: basi per una corretta strategia vaccinale” 199
Totale 29.391
Categoria #
all - tutte 139.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021555 0 0 0 0 0 0 0 0 0 0 221 334
2021/20222.498 185 264 142 176 152 89 113 124 130 206 308 609
2022/20234.308 250 458 509 519 364 711 228 375 351 171 208 164
2023/20244.411 141 114 404 291 213 977 1.262 171 71 205 235 327
2024/20259.396 392 415 948 436 1.039 703 774 673 901 443 856 1.816
2025/202620.402 1.383 2.745 3.376 2.742 3.910 780 2.356 710 816 1.223 361 0
Totale 48.813